The Institute for Clinical and Experimental Medicine (IKEM) is the only clinical center in the Czech Republic combining the full spectrum of therapies for diabetes and cardiovascular diseases, from various types of pharmacotherapies and standard invasive interventions to transplantation therapy for organ failure (heart, liver, kidneys, pancreas, and pancreatic islets). Intensive clinical, experimental, and translational research is conducted in each of these areas. In experimental research, IKEM primarily focuses on the study of experimental pathophysiological and physiological models pertaining to cardiovascular diseases, transplantation, diabetology, obesitology, and kidney disease. Most experimental research activities are conducted at the Experimental Medicine Centre (EMC), which also serves as a base for postgraduate studies in molecular biology and genetics, physiology and pathophysiology, biochemistry and pathobiochemistry, and metabolic disorders. In 2018, the Research, Development, and Innovation Council of the Government of the Czech Republic ranked IKEM an outstanding Class A research organization based on a new methodology known as M17+.
Official website >